![Charles Sermon](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Charles Sermon
Gründer bei
MEREO BIOPHARMA GROUP PLC
Vermögen: 75 357 $ am 31.05.2026
Profil
Mr. Charles E.
Sermon is a Secretary, General Counsel & Business Development at Mereo BioPharma Group Plc.
He is on the Board of Directors at Mereo BioPharma 2 Ltd., Mereo BioPharma 3 Ltd., Mereo BioPharma 4 Ltd. and Rainbow Trust Children's Charity.
Mr. Sermon was previously employed as a Member-Digital, Creative & Science by London Enterprise Panel and a Partner by Phase4 Partners Ltd. He received his graduate degree from The University of Hull.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 26.03.2026 | 1.095.309 ( 0,14 % ) | 75 357 $ | 31.05.2026 |
Aktive Positionen von Charles Sermon
| Unternehmen | Position | Beginn |
|---|---|---|
| MEREO BIOPHARMA GROUP PLC | Gründer | 01.03.2015 |
Mereo Biopharma 3 Ltd.
 Mereo Biopharma 3 Ltd. BiotechnologyHealth Technology Develops bio pharm products | Direktor/Vorstandsmitglied | - |
Mereo BioPharma 2 Ltd.
 Mereo BioPharma 2 Ltd. Miscellaneous Commercial ServicesCommercial Services Provides research and experimental development for biotechnology | Direktor/Vorstandsmitglied | 30.06.2015 |
Mereo BioPharma 4 Ltd.
 Mereo BioPharma 4 Ltd. Miscellaneous Commercial ServicesCommercial Services Provides biotechnological research and development services | Direktor/Vorstandsmitglied | 24.10.2017 |
Rainbow Trust Children's Charity
 Rainbow Trust Children's Charity Miscellaneous Commercial ServicesCommercial Services Provides emotional and practical support services | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Charles Sermon
| Unternehmen | Position | Ende |
|---|---|---|
Phase4 Partners Ltd.
 Phase4 Partners Ltd. Investment ManagersFinance Phase4 Ventures invests in companies located in the United Kingdom. The firm focuses on a broad range of sectors and industries. It Participates in early and later stage capital requirements with an investment size of USD 15 - 30 million. | Mitglied des Investmentausschusses | 28.02.2022 |
London Enterprise Panel | Corporate Officer/Principal | 01.01.2016 |
Ausbildung von Charles Sermon
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
29
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
Phase4 Partners Ltd.
Phase4 Partners Ltd. Investment ManagersFinance Phase4 Ventures invests in companies located in the United Kingdom. The firm focuses on a broad range of sectors and industries. It Participates in early and later stage capital requirements with an investment size of USD 15 - 30 million. | Finance |
The University of Hull
 The University of Hull Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rainbow Trust Children's Charity
Rainbow Trust Children's Charity Miscellaneous Commercial ServicesCommercial Services Provides emotional and practical support services | Commercial Services |
Mereo BioPharma Group Plc
 Mereo BioPharma Group Plc BiotechnologyHealth Technology Operates as a biopharmaceutical company | Health Technology |
London Enterprise Panel | |
Mereo Biopharma 3 Ltd.
Mereo Biopharma 3 Ltd. BiotechnologyHealth Technology Develops bio pharm products | Health Technology |
Mereo BioPharma 2 Ltd.
Mereo BioPharma 2 Ltd. Miscellaneous Commercial ServicesCommercial Services Provides research and experimental development for biotechnology | Commercial Services |
Mereo BioPharma 4 Ltd.
Mereo BioPharma 4 Ltd. Miscellaneous Commercial ServicesCommercial Services Provides biotechnological research and development services | Commercial Services |
